These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38956992)

  • 1. Pulmonary arterial hypertension in systemic sclerosis: a national inpatient analysis.
    Sami H; Sami F; Razok A; Dasgupta M; Gajjar R
    ARP Rheumatol; 2024; 3(2):95-100. PubMed ID: 38956992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample.
    Ram Poudel D; George M; Dhital R; Karmacharya P; Sandorfi N; Derk CT
    Rheumatology (Oxford); 2018 Sep; 57(9):1611-1622. PubMed ID: 29868788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Sclerosis Is Associated With Increased Inpatient Mortality in Patients Admitted for Atrial Fibrillation: Analysis of the National Inpatient Sample.
    Edigin E; Ojemolon PE; Eseaton PO; Shaka H; Akuna E; Asemota IR; Manadan A
    J Clin Rheumatol; 2021 Dec; 27(8):e477-e481. PubMed ID: 32947436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalizations and mortality in systemic sclerosis: results from the Nationwide Inpatient Sample.
    Chung L; Krishnan E; Chakravarty EF
    Rheumatology (Oxford); 2007 Dec; 46(12):1808-13. PubMed ID: 17986481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty-day hospital readmission in systemic sclerosis associated pulmonary hypertension: A nationwide study.
    Showalter K; Ma X; Pinheiro L; Sobol I; Gordon JK; Mehta B
    Semin Arthritis Rheum; 2021 Feb; 51(1):324-330. PubMed ID: 33465591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National trends and inpatient outcomes of pulmonary arterial hypertension related hospitalizations - Analysis of the National Inpatient Sample Database.
    Chaturvedi A; Kanwar M; Chandrika P; Thenappan T; Raina A; Benza RL
    Int J Cardiol; 2020 Nov; 319():131-138. PubMed ID: 32603739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with pulmonary arterial hypertension in Colombian patients with systemic sclerosis: review of the literature.
    Coral-Alvarado P; Rojas-Villarraga A; Latorre MC; Mantilla RD; Restrepo JF; Pardo AL; Chalem P; Rondón F; Jáuregui E; Rueda JC; Cañas C; Hincapie ME; Pineda-Tamayo R; Alvarez F; Iglesias-Gamarra A; Diaz FJ; Anaya JM
    J Rheumatol; 2008 Feb; 35(2):244-50. PubMed ID: 18203318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
    Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
    Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis.
    Nietert PJ; Silverstein MD; Silver RM
    J Rheumatol; 2001 Sep; 28(9):2031-7. PubMed ID: 11550971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide study.
    Sarı A; Satış H; Ayan G; Küçükşahin O; Kalyoncu U; Fidancı AA; Ayvalı MO; Ata N; Ülgü MM; Birinci Ş; Akdoğan A
    Clin Rheumatol; 2024 Jun; 43(6):1919-1925. PubMed ID: 38676757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scleroderma hypertensive renal crisis among systemic sclerosis patients: A national emergency department database study.
    Uddin M; Mir T; Surapaneni S; Mehar A; Dar T; Changal K; Ullah W; Lohia P; Bhat Z; Sheikh M; Burket M
    Am J Emerg Med; 2022 Mar; 53():228-235. PubMed ID: 35078051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung involvement in systemic sclerosis is associated with adverse hospital outcomes: insights from the National Inpatient Sample.
    Odion JO; Guraya A; Muojieje CC; Idolor ON; Sanwo EJ; Aihie OP
    J Investig Med; 2021 Jun; 69(5):1022-1026. PubMed ID: 33589444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort.
    Noviani M; Saffari SE; Tan JL; Yip JWL; Teng GG; Law WG; Chan GYL; Santosa A; Lim AYN; Hong C; Ng SA; Tay ELW; Ruan W; Yap J; Low AHL
    Semin Arthritis Rheum; 2020 Jun; 50(3):473-479. PubMed ID: 31810742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient Palliative Care Use in Patients With Pulmonary Arterial Hypertension: Temporal Trends, Predictors, and Outcomes.
    Anand V; Vallabhajosyula S; Cheungpasitporn W; Frantz RP; Cajigas HR; Strand JJ; DuBrock HM
    Chest; 2020 Dec; 158(6):2568-2578. PubMed ID: 32800817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic.
    Jansa P; Becvar R; Ambroz D; Palecek T; Tomcik M; Skacelova S; Aschermann M; Linhart A
    Clin Rheumatol; 2012 Mar; 31(3):557-61. PubMed ID: 22105781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?
    Senturk B; Akdeniz B; Yilmaz MB; Ozcan Kahraman B; Acar B; Uslu S; Birlik M
    Clin Rheumatol; 2020 Jan; 39(1):49-56. PubMed ID: 31129792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans.
    Blanco I; Mathai S; Shafiq M; Boyce D; M Kolb T; Chami H; K Hummers L; Housten T; Chaisson N; L Zaiman A; M Wigley F; J Tedford R; A Kass D; Damico R; E Girgis R; M Hassoun P
    Medicine (Baltimore); 2014 Jul; 93(5):177-185. PubMed ID: 25181310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longterm Efficacy and Safety of Monotherapy versus Combination Therapy in Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Retrospective RESCLE Registry Study.
    Pestaña-Fernández M; Rubio-Rivas M; Tolosa-Vilella C; Guillén-Del-Castillo A; Freire M; Vargas-Hitos JA; Todolí-Parra JA; Rodríguez-Carballeira M; Marín-Ballvé A; Espinosa G; Colunga-Argüelles D; Ortego-Centeno N; Trapiella-Martínez L; Carbonell-Muñoz C; Pla-Salas X; Perales-Fraile I; Corbella X; Fonollosa-Pla V; Simeón-Aznar CP;
    J Rheumatol; 2020 Jan; 47(1):89-98. PubMed ID: 30770503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is pulmonary arterial hypertension really a late complication of systemic sclerosis?
    Hachulla E; Launay D; Mouthon L; Sitbon O; Berezne A; Guillevin L; Hatron PY; Simonneau G; Clerson P; Humbert M;
    Chest; 2009 Nov; 136(5):1211-1219. PubMed ID: 19429720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subclinical coronary atherosclerosis, detected by computer tomography with coronary calcium score, and the occurrence of major cardiovascular events at 5 years of follow-up in a cohort of patients with systemic sclerosis.
    Rotondo C; Sciacca S; Rella V; Busto G; Colia R; Cantatore FP; Corrado A
    Eur J Intern Med; 2023 Sep; 115():62-69. PubMed ID: 37316356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.